Tocilizumab er udviklet til at binde sig til receptoren for et signalstof (cytokin) i kroppen, som kaldes interleukin- 6.
Tocilizumab has been designed to bind to the receptor for a messenger molecule (cytokine) in the body called interleukin-6.